Patients & Caregivers

Our Commitment

Innovating for You

We are working as urgently as possible to develop new therapies for patients with autoimmune diseases to help them reimagine life.

Our commitment to you is that we will:

  • Work as rapidly and efficiently as possible, because too much is at stake.

  • Honor our values in our interactions.

  • Apply our team’s deep expertise, rigor and passion to advance innovative new therapies.

  • Understand that there is not a one-size-fits-all approach to treating autoimmune diseases.

  • Stay curious and welcome opportunities to connect with you and healthcare professionals to understand your experiences and needs.

  • Stay optimistic about the possibility of delivering innovative therapies based on clinically validated science that could make a significant difference for you.

Zenas BioPharma is committed to developing innovative therapies with the highest standards of safety, ethics, and scientific rigor. As our medicines are still in clinical development, we do not currently offer an expanded access (compassionate use or other early access) program. At this time, patients may only access our investigational therapies by participating in ongoing clinical trials, if eligible.

Learn more: